Inventor · disambiguated record
Christopher Hovens
Also filed as: HOVENS CHRISTOPHER · HOVENS CHRISTOPHER M
3 granted patents·9 pending applications·6 citations·filing 1993–2015
61Inventor score
Top patents by PatentIndex Score
12 records- 0159US8920851B2Treatment of neurodegenerative diseasesHOVENS CHRISTOPHER·Filed 2007·Granted Dec 30, 2014·2 cites·9 claims
- 0255US9415063B2Treatment of neurological disordersVELACOR THERAPEUTICS PTY LTD·Filed 2015·Granted Aug 16, 2016·1 cites·7 claims
- 0345US2010092477A1Methods and compositions for treating prostate cancerHOVENS CHRISTOPHER·Filed 2009·Application pending·0 cites
- 0444US2010291233A1Treatment of neurological disordersVELACOR THERAPEUTICS PTY LTD·Filed 2008·Application pending·0 cites
- 0537US2011144032A1Biological applications of steroid binding domainsHOVENS CHRISTOPHER·Filed 2009·Application pending·0 cites
- 0635US6107472AReceptor-type tyrosine kinase-like moleculesLUDWIG INST CANCER RES·Filed 1993·Granted Aug 22, 2000·3 cites·12 claims
- 0735US2010291086A1Use of estrogen and androgen binding proteins in methods and compositions for treating gynaecological cancersHOVENS CHRISTOPHER·Filed 2008·Application pending·0 cites
- 0834US2008081039A1Inorganic Selenium For Treatment Of CancerVELACOR THERAPEUTICS PTY LTD·Filed 2005·Application pending·0 cites
- 0933US2013064821A1Methods and compositions for treating prostate cancerHOVENS CHRISTOPHER·Filed 2012·Application pending·0 cites
- 1033US2014141104A1Treatment of neurodegenerative diseasesVELACOR THERAPEUTICS PTY LTD·Filed 2013·Application pending·0 cites
- 1132US2004115660A1Method of diagnosising abnormalities by screening for tyrosine kinase like molecules or their signalling mediatorsFiled 2001·Application pending·0 cites
- 1228US2015140130A1Treatment of neurological disordersVELACOR THERAPEUTICS PTY LTD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christopher Hovens files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →